Patent ID: 6919376

Claim:
A pharmaceutical composition comprising a unit dosage form comprising a pharmaceutically acceptable carrier or diluent containing a therapeutically effective amount for treatment of cancer in a patient of a chemical having the formula: wherein R 1 , R 2 , R 3 , R 4 , and R 5 are independently chosen from the group consisting of H, OH, C 1 -C 3 alkyl, a halogen, primary amine, secondary amine, tertiary amine, carboxy, alkoxy, alkyoxycarbonyl, carboxamido, and C 1 -C 3 alkenyl; wherein R 6 and R 7 are independently chosen from the group consisting of H, C 1 -C 3 alkyl, and C 1 -C 3 alkenyl; and, wherein R 8 , and R 9 are independently chosen from the group consisting of chemical groups having 1 to 12 carbons; or a pharmaceutically acceptable salt thereof.